Atai Life Sciences (ATAI) Q3 2024 Earnings
ATAI·Reported November 13, 2024·Before market open
Atai Life Sciences reported Q3 2024 revenue of $40.0K, missed analyst consensus of $250.0K by $210.0K. Diluted EPS came in at $-0.16, missed the $-0.15 consensus by $0.01.
Revenue
$40.0Kmissed by $210.0K
Consensus: $250.0KDiluted EPS
$-0.16missed by $0.01
Consensus: $-0.15
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Atai Life Sciences 's Q3 2024 earnings report.
Atai Life Sciences (ATAI) reported Q3 2024 earnings on November 13, 2024 before market open.
Atai Life Sciences reported revenue of $40.0K and diluted EPS of $-0.16 for Q3 2024.
Revenue missed the consensus estimate of $250.0K by $210.0K. EPS missed the consensus estimate of $-0.15 by $0.01.
You can read the 10-Q periodic report (0000950170-24-126515) directly on SEC EDGAR. The filing index links above go to sec.gov.